Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on peptides and GLP-1. Browse all Peptides & GLP-1 education

A genetic test that delivers 150+ insights is only as useful as your ability to read it. The Precision Peptide Genetic Test returns a detailed report through the secure PlexusDx Results Portal — organized across 14 pathways, 49 peptides, and 150+ genetic insights. But 150+ insights can feel like information overload without a framework for reading them. This guide walks through that framework: how pathway scores are structured, how to interpret individual gene variants, how to recognize cross-pathway patterns, and how to turn the whole picture into the informed conversation every peptide protocol decision should start with.

The Structure of Your Report

Your results arrive as a report, not a raw data file. It's organized by biological pathway — 14 in total, each with its own section. At the top of each pathway section, you'll see the number of insights analyzed for that pathway (34 for Weight Management, 17 for Longevity & Aging, 15 for Muscle Growth, 14 for Skin Health, 12 for Energy Metabolism, and so on). Below the pathway header, individual gene insights are listed with their specific variant, the research-backed interpretation, and how that variant fits into the larger pathway story. The report is designed to be read pathway-by-pathway — you don't need to review all 150+ insights in one sitting.

How to Read Pathway Summaries

Each pathway in your report reflects a composite view of how your genetic baseline is positioned across that biological system. A pathway summary isn't a test grade — it's a synthesis of the variant-level findings into plain-language context about your tendencies in that pathway. A Weight Management pathway summary reflects how your variants across FTO, MC4R, TCF7L2, GLP1R, and PPARG come together to shape appetite regulation, satiety signaling, and metabolic response. A Longevity pathway summary reflects how FOXO3, SOD2, APOE, SIRT1, and TERT interact across cellular resilience, oxidative stress, and aging trajectory.

How to Read Individual Gene Insights

Each gene insight has three parts: the variant itself (e.g., FTO rs9939609 AA genotype), what that variant means biologically (higher genetic contribution to appetite and satiety variability), and how it fits into pathway-level decisions (relevant when evaluating weight management interventions with a qualified healthcare provider). The language is deliberately non-prescriptive — the report describes what the variant is associated with, not what you should do about it. That's because genetic tendencies interact with lifestyle, environment, and clinical context in ways that require provider interpretation.

Interpreting Genotypes and Alleles

Some variants are reported as genotypes (e.g., COMT Val/Val, Val/Met, or Met/Met — which combination of two alleles you carry). Others are reported as presence/absence (e.g., GSTM1 null — indicating the absence of functional enzyme activity). Some are reported as rs numbers paired with specific alleles (e.g., FTO rs9939609 AA or AG or GG). The report explains each genotype in plain terms, so you don't need prior genetics training — but if you want to dig deeper into the biology of a particular gene, the pathway pillar posts walk through specific variants in depth. For longevity-related variants, see our guide to genetic longevity testing. For estrogen clearance and women's hormone genetics, see our guide to genetic women's hormone testing.

Cross-Pathway Findings — The Synthesis Layer

Variants don't exist in isolation. A slow-COMT variant means more when paired with a slow-MTHFR variant because both constrain methylation capacity. A less responsive GHR variant matters differently depending on what your IGF1 profile looks like. A high-aromatase CYP19A1 variant interacts with your SHBG profile to shape total male hormone biology. The base report flags major cross-pathway interactions, but the Peptide Pathways Report is the deeper synthesis layer — organizing findings by protocol decision rather than by pathway, so you can move from "here's my biology" to "here's what my biology implies" without additional interpretation work.

What to Do With Your Results

The most important next step is a conversation with a qualified healthcare provider. Your genetic results don't diagnose any condition and don't prescribe any protocol. What they do is shift the quality of the conversation: instead of starting from generic population averages, the provider has your specific genetic context as input. The provider makes clinical judgments. You and the provider translate those judgments into protocols that fit your biology. Your results become a reference document for every future hormone, peptide, supplement, or nutrition decision — a foundation layer that stays relevant as long as you do.

Genetics as a Guide, Not a Guarantee

Your results reveal tendencies, not outcomes. A favorable FOXO3 variant doesn't guarantee healthy aging; a fast-aromatase CYP19A1 variant doesn't predetermine any specific hormone trajectory. Lifestyle, environment, age, sleep, stress, and clinical context all interact with your genetic baseline. The real value of your report isn't prediction — it's precision. Every decision at every layer of the precision health stack is better-informed with your genetic context in hand. That's the framework behind testing before you invest in any peptide protocol.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to understand what your genes say about your peptide response? Take the Precision Peptide Genetic Test

Frequently Asked Questions

How do I interpret my Precision Peptide Genetic Test results?

Read your report pathway by pathway. Each of the 14 pathways summarizes how your variants work together — Weight Management covers FTO, MC4R, TCF7L2; Longevity covers FOXO3, SOD2, APOE, SIRT1, TERT. Individual gene insights include the variant, what it means biologically, and how it informs protocol decisions with a qualified healthcare provider.

What's the difference between the Results Portal and Peptide Pathways Report?

The Results Portal delivers your base report — 150+ insights across 14 pathways, organized by pathway. The Peptide Pathways Report is a deeper synthesis layer, organizing findings by protocol decision rather than pathway. Results Portal shows what your genetics reveal; the Peptide Pathways Report shows what it implies across cross-pathway interactions.

What should I do with my genetic test results?

Share them with a qualified healthcare provider. Your 150+ insights across 14 pathways provide genetic context for every peptide, hormone, supplement, or nutrition decision. The provider makes clinical judgments; your results improve the quality of those judgments. One Precision Peptide Genetic Test informs every protocol decision for the rest of your life.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.